Section Arrow
Quote
SVA.NASDAQ
- Sinovac Biotech Ltd
  suspend
Quotes are at least 15-min delayed:2026/06/10 00:51 EDT
Regular Hours
Last
 --
-- (--)
Day High 
-- 
Prev. Close
6.47 
1-M High
-- 
Volume 
-- 
Bid
--
Ask
--
Day Low
-- 
Open
-- 
1-M Low
-- 
Market Cap 
460.25M 
Currency 美元 
P/E 19.03 
%Yield -- 
10-SMA 6.51 
20-SMA 6.5 
50-SMA 6.64 
52-W High -- 
52-W Low -- 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-1.31/--
Enterprise Value
482.07M
Balance Sheet
Book Value Per Share
3.56
Cash Flow
Cash Flow Yield
0.12
Income Statement
Total Revenue
448.27M
Operating Revenue Per Share
3.23
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
ADTXAditxt Inc.0.0289-0.021-42.08%-- 
NUVLNuvalent123.25+34.76+39.28%-- 
RXRXRecursion Pharmaceuticals3.22-0.1-3.01%-- 
GERNGeron Corp1.12-0.01-0.88%-- 
GOSSGossamer Bio0.16-0.0056-3.38%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Sinovac Biotech Ltd is a fully integrated China-based biopharmaceutical company engaged in the research, development, manufacturing, and commercialization of vaccines for infectious diseases. Its products include vaccines for hepatitis A, hepatitis B, EV-A71, seasonal influenza, H5N1 and H1N1 pandemic influenza, coronavirus, pneumococcus, poliomyelitis, varicella, mumps, and tetanus. The Company generates maximum revenue from Mainland China.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.